SARMS-Andarine S-4: Compound Profile
Andarine S-4 is a non-steroidal selective androgen receptor modulator (SARM) originally developed for investigating tissue-selective androgenic activity. This compound demonstrates partial agonist activity at androgen receptors, showing preferential binding affinity for bone and muscle tissue over prostate tissue in preclinical models. Researchers at Stroid UK Shop can examine S-4’s unique receptor selectivity profile across various tissue types. Development of this compound was discontinued after Phase I clinical trials, making it available exclusively for research applications.
Laboratory Applications
Andarine S-4 enables researchers to investigate androgen receptor modulation pathways and tissue-specific responses. Studies have examined its effects in models of osteoporosis and muscle wasting conditions, providing insights into selective androgenic mechanisms. Laboratories studying Andarine S-4 compounds can analyse receptor binding kinetics and downstream signalling pathways. The compound’s partial agonist properties offer unique research opportunities compared to full agonists. Research applications extend to investigating bone density maintenance and muscle tissue preservation mechanisms. Scientists can examine dose-response relationships and tissue distribution patterns using established analytical methods. These SARM research compounds complement broader investigations into selective receptor modulation. Comparative studies with peptide modulators provide additional research perspectives.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Andarine (S-4) |
| Concentration | 25mg per capsule |
| CAS Number | 401900-40-1 |
| Molecular Formula | C₁₉H₁₈F₃N₃O₆ |
| Molecular Weight | 441.36 g/mol |
| Manufacturer | Beligas |
| Form | Capsule |
| Storage | Room temperature, protect from light |
Research Compliance
This product is supplied strictly for in-vitro laboratory research purposes only. Not approved for human consumption, clinical trials, or therapeutic applications. Researchers must follow appropriate laboratory safety protocols and disposal procedures. Intended exclusively for qualified research institutions and licensed laboratories conducting legitimate scientific investigations into androgen receptor mechanisms.
